.. and the New York Times also reports that F.D.A. Approval of Nasal Vaccine for Flu Expected.
Flumist – developed at the University of Michigan – and to be sold by MedImmunie – will be indicated for people 5 to 50 years old.
Yes .. you heard that right. The populations for whom influenza vaccine is reccomended are the populations for whom Flumist is not indicated.
It'll also cost much more.
We lost about $1500 last season on flu shots that we bought and never gave to people .. so I don't think I'll invest in any flumist this coming winter
